Gossamer Bio, Inc.

GOSSNASDAQHealthcare● Active

$0.17

$-0.01(-4.97%)

Market Cap$39029992

P/E Ratio—

52W High$3.87

52W Low$0.163

Avg Volume10.6M

Open$0.18

Beta2.00

Cash on Hand Financials Revenue

Gossamer Bio, Inc. (GOSS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GOSS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$136.9M▼ -53.5% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$37.7M

cashAndCashEquivalents

Short-Term Investments

$99.2M

shortTermInvestments

YoY Change vs Prior Year

-53.5%

vs prior fiscal year

Latest Quarter

$99.2M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$136.9MCash on Hand

Total Debt$202.0MTotal Debt

Net Cash / Net Debt−$65.0MNet Debt Position

Cash vs Debt Ratio

Cash 40%Gossamer Bio, Inc. cash as % of market cap: 350.84%% · MCap $0BDebt 60%

Gossamer Bio, Inc. carries a net debt position of $65.0M. Total debt ($202.0M) exceeds cash on hand ($136.9M). Gossamer Bio, Inc. cash vs debt ratio: 40% cash / 60% debt.

Net Cash = Cash & ST Investments − Total Debt$136.9M − $202.0M = −$65.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GOSS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GOSS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$136.9M-53.5%

Dec 31, 2024FY$294.5M-0.6%

Dec 31, 2023FY$296.4M+15.9%

Dec 31, 2022FY$255.7M-21.4%

Dec 31, 2021FY$325.2M-36.6%

GOSS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GOSS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Gossamer Bio, Inc.YOU

GOSS

$136.9M$39M351.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Gossamer Bio, Inc. (GOSS) cash on hand as of December 31, 2025 is $136.9M, comprising $37.7M in cash and cash equivalents (CCE) plus $99.2M in short-term investments — reported as Gossamer Bio, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Gossamer Bio, Inc. cash reserves or cash position.

Gossamer Bio, Inc. annual cash on hand history shows decreased -53.5% in 2025: decreased -53.5% in 2025. Gossamer Bio, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Gossamer Bio, Inc. carries total debt of $202.0M against cash of $136.9M, resulting in a net debt position of -$65.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GOSS cash on hand · 5 questions

As of December 31, 2025, Gossamer Bio, Inc. (GOSS) has $136,932,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $37,732,000 in cash and cash equivalents (CCE) plus $99,200,000 in short-term investments. Latest quarter (March 31, 2026): $99,215,000. Data sourced from the annual 10-K filing via FMP.

GOSS cash on handGOSS cash reservesGOSS cash 2025how much cash does GOSS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Gossamer Bio, Inc. · Gossamer Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025